GL1X · GenesisL1 explorer

Research workbench

Structure of human dihydroorotate dehydrogenase with a bound inhibitor

Analyse Structure of human dihydroorotate dehydrogenase with a bound inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZWT
Type
protein
Length
353 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.3.1, 1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, KFZ, SO4, CL
Pockets
3 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.3.1, 1.3.5.2)protein35345% helix, 17% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • KFZ · 2-{[(2,5-dichlorophenyl)methyl]sulfanyl}-5-ethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • CL · Chloride ion · ion · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14210.830.9161FMN, ORO, KFZ
2950.450.8020ACT
3950.450.8018SO4

Compared structures

  • 3ZWT · Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.